{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T06:03:16Z","timestamp":1784354596912,"version":"3.55.0"},"reference-count":21,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T00:00:00Z","timestamp":1637020800000},"content-version":"vor","delay-in-days":1915,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,8,19]]},"abstract":"<jats:title>Summary<\/jats:title>\n               <jats:p>Hereditary angioedema (HAE) is a rare disease associated with either a quantitative or qualitative deficiency in C1-inhibitor (C1-INH) or normal C1-INH. HAE with normal C1-INH is associated in 20% of cases with mutations in the gene for factor XII (FXII) or FXII-HAE. A recent review described 41 families, including 14 German and 15 Spanish families. We have constructed a register of French patients and their characteristics. A national survey was launched through the French National Center of Reference for Angioedema (CREAK) to study the clinical, biological and therapeutic characteristics of patients with HAE linked to a mutation of FXII gene. Fifty-seven patients were identified from 24 different families. In most cases they were young women (mean age at diagnosis: 31 years, mean age at first symptom: 21 years, female\/male ratio: 76%). Twenty-one per cent of the patients experienced angioedema attacks only during pregnancy or when on oestrogen contraception. Sixty-three per cent had attacks at all times, but they were more severe during these same periods. Male carriers of the mutation were more frequently asymptomatic than females (P = 0\u00b7003). C1-INH concentrate and icatibant were both effective for treating attacks. The prophylactic use of tranexamic acid led to a 64% decrease in the number of attacks. This is one of the largest series reported of HAE patients with FXII mutation. The therapeutic management appeared to be identical to that of HAE with C1-INH deficiency.<\/jats:p>","DOI":"10.1111\/cei.12820","type":"journal-article","created":{"date-parts":[[2016,6,7]],"date-time":"2016-06-07T08:53:30Z","timestamp":1465289610000},"page":"332-337","source":"Crossref","is-referenced-by-count":53,"title":["Hereditary angioedema with normal C1 inhibitor and factor XII mutation: a series of 57 patients from the French National Center of Reference for Angioedema"],"prefix":"10.1093","volume":"185","author":[{"given":"A","family":"Deroux","sequence":"first","affiliation":[{"name":"Internal Medicine Department, Centre Hospitalier Des Alpes, Grenoble, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Boccon-Gibod","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, Centre Hospitalier Des Alpes, Grenoble, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O","family":"Fain","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, H\u00f4pital Saint Antoine, Universit\u00e9 Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Pralong","sequence":"additional","affiliation":[{"name":"Dermatology Department, Allergology and Photobiology, CHU De Grenoble, Grenoble, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Ollivier","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, Caen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Pagnier","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, Centre Hospitalier Des Alpes, Grenoble, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Djenouhat","sequence":"additional","affiliation":[{"name":"Service De Biologie M\u00e9dicale, EPH De Rou\u00efba, Alger, Alg\u00e9ria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Du-Thanh","sequence":"additional","affiliation":[{"name":"Dermatology Department, H\u00f4pital Saint-Eloi, Centre Hospitalier Universitaire De Montpellier, Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Gompel","sequence":"additional","affiliation":[{"name":"Gynecology Department, CHU Paris-Centre, Hopital, Cochin, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Faisant","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, Centre Hospitalier Des Alpes, Grenoble, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Launay","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Lille, Lille Inflammation Research International Center, Lille, France"},{"name":"D\u00e9partement De M\u00e9decine Interne Et Immunologie Clinique, Lille, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Bouillet","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, Centre Hospitalier Des Alpes, Grenoble, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2016,8,19]]},"reference":[{"key":"2021111804093131700_cei12820-bib-0001","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0140-6736(00)02483-1","article-title":"Hereditary angioedema with normal C1-inhibitor activity in women","volume":"356","author":"Bork","year":"2000","journal-title":"Lancet"},{"key":"2021111804093131700_cei12820-bib-0002","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1067\/mai.2000.108106","article-title":"Clinical, biochemical, and genetic characterization of a novel estrogen-dependent inherited form of angioedema","volume":"106","author":"Binkley","year":"2000","journal-title":"J Allergy Clin Immunol"},{"key":"2021111804093131700_cei12820-bib-0003","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S1567-5769(02)00162-5","article-title":"Bradykinin and the pathophysiology of angioedema","volume":"3","author":"Cugno","year":"2003","journal-title":"Int Immunopharmacol"},{"key":"2021111804093131700_cei12820-bib-0004","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.bbrc.2006.03.092","article-title":"Missense mutations in the coagulation factor XII (Hageman factor) gene in hereditary angioedema with normal C1 inhibitor","volume":"343","author":"Dewald","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"2021111804093131700_cei12820-bib-0005","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.amjmed.2007.08.021","article-title":"Hereditary angioedema with normal C1 inhibitor: clinical symptoms and course","volume":"120","author":"Bork","year":"2007","journal-title":"Am J Med"},{"key":"2021111804093131700_cei12820-bib-0006","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1086\/509899","article-title":"Increased activity of coagulation factor XII (Hageman factor) causes hereditary angioedema type III","volume":"79","author":"Cichon","year":"2006","journal-title":"Am J Hum Genet"},{"key":"2021111804093131700_cei12820-bib-0007","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.jaci.2007.07.002","article-title":"Hereditary angioedema with normal C1 inhibitor gene in a family with affected women and men is associated with the p.Thr328Lys mutation in the F12 gene","volume":"120","author":"Martin","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"2021111804093131700_cei12820-bib-0008","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1398-9995.2008.01764.x","article-title":"Missense mutation Thr309Lys in the coagulation factor XII gene in a Spanish family with hereditary angioedema type III","volume":"64","author":"Prieto","year":"2009","journal-title":"Allergy"},{"key":"2021111804093131700_cei12820-bib-0009","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jdermsci.2009.06.013","article-title":"Recurrent European missense mutation in the F12 gene in a British family with type III hereditary angioedema","volume":"56","author":"Nagy","year":"2009","journal-title":"J Dermatol Sci"},{"key":"2021111804093131700_cei12820-bib-0010","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1111\/j.1398-9995.2010.02368.x","article-title":"Type III hereditary angiooedema: clinical and biological features in a French cohort","volume":"65","author":"Vitrat-Hincky","year":"2010","journal-title":"Allergy"},{"key":"2021111804093131700_cei12820-bib-0011","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jaci.2009.03.038","article-title":"Hereditary angioedema caused by missense mutations in the factor XII gene: clinical features, trigger factors and therapy","volume":"124","author":"Bork","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"2021111804093131700_cei12820-bib-0012","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.clim.2013.08.001","article-title":"Novel duplication in the F12 gene in a patient with recurrent angioedema","volume":"149","author":"Kiss","year":"2013","journal-title":"Clin Immunol"},{"key":"2021111804093131700_cei12820-bib-0013","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1398-9995.2011.02751.x","article-title":"Evidence-based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: consensus report of an International Working Group","volume":"67","author":"Cicardi","year":"2012","journal-title":"Allergy"},{"key":"2021111804093131700_cei12820-bib-0014","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.anai.2013.07.012","article-title":"French National Reference Center for Hereditary Angioedema (CREAK). Hereditary angioedema with C1 inhibitor deficiency: clinical presentation and quality of life of 193 French patients","volume":"111","author":"Bouillet","year":"2013","journal-title":"Ann Allergy Asthma Immunol"},{"key":"2021111804093131700_cei12820-bib-0015","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.clim.2015.02.013","article-title":"Characterization of patients with angioedema without wheals: the importance of F12 gene screening","volume":"157","author":"Firinu","year":"2015","journal-title":"Clin Immunol"},{"key":"2021111804093131700_cei12820-bib-0016","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/all.12380","article-title":"Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group","volume":"69","author":"Cicardi","year":"2014","journal-title":"Allergy"},{"key":"2021111804093131700_cei12820-bib-0017","doi-asserted-by":"crossref","first-page":"957507","DOI":"10.1155\/2010\/957507","article-title":"Obstetrical complications and outcome in two families with hereditary angioedema due to mutation in the F12 gene","volume":"2010","author":"Picone","year":"2010","journal-title":"Obstet Gynecol Int"},{"key":"2021111804093131700_cei12820-bib-0018","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1111\/j.1365-2133.2007.07778.x","article-title":"A case of hereditary angioedema type III presenting with C1-inhibitor cleavage and a missense mutation in the F12 gene","volume":"156","author":"Bouillet","year":"2007","journal-title":"Br J Dermatol"},{"key":"2021111804093131700_cei12820-bib-0019","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1016\/j.jaci.2015.07.041","article-title":"Deficiency of plasminogen activator inhibitor 2 in plasma of patients with hereditary angioedema with normal C1 inhibitor levels","volume":"137","author":"Joseph","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"2021111804093131700_cei12820-bib-0020","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/cea.12055","article-title":"Benefits of progestin contraception in non-allergic angioedema","volume":"43","author":"Saule","year":"2013","journal-title":"Clin Exp Allergy"},{"key":"2021111804093131700_cei12820-bib-0021","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/cea.12080","article-title":"Update on treatment of hereditary angioedema","volume":"43","author":"Xu","year":"2013","journal-title":"Clin Exp Allergy"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fcei.12820","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fcei.12820","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/185\/3\/332\/41126544\/cei12820.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/185\/3\/332\/41126544\/cei12820.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T16:27:14Z","timestamp":1641054434000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/185\/3\/332\/6412108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,19]]},"references-count":21,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2016,8,19]]},"published-print":{"date-parts":[[2016,8,19]]}},"URL":"https:\/\/doi.org\/10.1111\/cei.12820","relation":{},"ISSN":["1365-2249","0009-9104"],"issn-type":[{"value":"1365-2249","type":"electronic"},{"value":"0009-9104","type":"print"}],"subject":[],"published-other":{"date-parts":[[2016,9]]},"published":{"date-parts":[[2016,8,19]]}}}